Current trends in the epidemiology and outcomes of clostridium difficile infection

Clinical Infectious Diseases

Volumn 60, Issue , 2015, Pages S66-S71

  Evans, Charlesnika T ^a,b   Safdar, Nasia ^c,d  

^a HINES VA HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

costs

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COST OF ILLNESS; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RISK FACTOR; UNITED STATES; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ECONOMICS; INTRAABDOMINAL INFECTIONS; NURSING HOME; PEPTOCLOSTRIDIUM DIFFICILE; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COST OF ILLNESS; CROSS INFECTION; HUMANS; INTRAABDOMINAL INFECTIONS; PREVALENCE; RISK FACTORS; SKILLED NURSING FACILITIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84928923377     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ140     Document Type: Article

References (44)

1. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16: 459-77.
2. Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE. SHEA Long-Term-Care Committee. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol 2002; 23: 696-703.
3. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12: 409-15.
4. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13: 1417-9.
5. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31: 431-55.
6. Lucado J, Gould C, Elixhauesr A. Clostridium difficile infections (CDI) in hospital stays, 2009, statistical brief 124. Healthcare Cost and Utilization Project (HCUP) statistical briefs, 2012.
7. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed 15 September 2014.
8. Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Met 2013; 173: 1359-67.
9. Gupta A, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist 2014; 7: 63-72.
10. Steiner C, Barret M, Weiss A. HCUP projections: Clostridium difficile hospitalizations 2001 to 2013. HCUP Projections Report # 2014-01. US Agency for Healthcare Research and Quality. Available at: http://www.hcup-us.ahrq.gov/reports/projections/2014-01.pdf. Accessed 11 September 2014.
11. Evans ME, Simbartl MS, Kralovic SM, Jain R, Roselle GA. Clostridium difficile infections in Veterans Health Administration acute care facilities. Infect Control Hosp Epidemiol 2014; 35: 1037-42.
12. Zilberberg MD, Tabak YP, Sievert DM, et al. Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011; 32: 649-55.
13. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009; 30: 526-33.
14. Tartof SY, Yu KC, Wei R, Tseng HF, Jacobsen SJ, Rieg GK. Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc 2014; 89: 1229-38.
15. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010; 31: 1030-7.
16. Benoit SR, McDonald LC, English R, Tokars JI. Automated surveillance of Clostridium difficile infections using BioSense. Infect Control Hosp Epidemiol 2011; 32: 26-33.
17. McDonald LC, Sievert DM, Gould C. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012; 61: 157-61.
18. Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of communityacquired Clostridium difficile infection: a population-based study. Am J Gastroenterology 2012; 107: 89-95.
19. Naggie S, Miller BA, Zuzak KB, et al. A case-control study of community associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 2011; 124: 276.e1-7.
20. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficileassociated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146: 95-100.
21. Yip C, Loeb M, Salama S, Moss L, Olde J. Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2001; 22: 572-5.
22. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003; 9: 730-3.
23. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 38: 640-5.
24. Alfa MJ, Harding GKM, Ronald AR, et al. Diarrhea recurrence in patients with Clostridium difficile-associated diarrhea: role of concurrent antibiotics. Can J Infect Dis 1999; 10: 287-300.
25. Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis 2011; 53: 440-7.
26. Petrella LA, Sambol SP, Cheknis A, et al. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012; 55: 351-7.
27. Shaughnessy MK, Amundson WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2012; 34: 109-16.
28. Deshpande A, Pasupuleti V, Thota P, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68: 1951-61.
29. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 2013; 57: 2326-32.
30. Janarthan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107: 1001-10.
31. Kwok CS, Arthur AK, Anibueze CL, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107: 1011-9.
32. Tleyjeh IM, Bin Abdulhak AB, Riaz M, et al. The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis. PLoS One 2013; 8: e56498.
33. Bakken JS, Polgreen PM, Beekmann SE, Riedo FX, Streit JA. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians. Anaerobe 2013; 24: 20-4.
34. Kasper AM, Nyazee HA, Yokoe DS, et al. Centers for Disease Control and Prevention Epicenters Program. A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol 2012; 33: 470-6.
35. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55: 216-23.
36. Gabriel L, Beriot-Mathiot A. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review. J Hosp Infect 2014; 88: 12-21.
37. Magill SS, Edwards JR, BambergW, et al. Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370: 1198-208.
38. Miller VA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011; 32: 387-90.
39. Evans ME, Kralovic SM, Simbartl LA, et al. Veterans Affairs methicillinresistant Staphylococcus aureus prevention initiative associated with a sustained reduction in transmissions and health care-associated infections. Am J Infect Control 2013; 41: 1093-5.
40. Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection. Clin Infect Dis 2012; 55(suppl 2): S65-70.
41. See I, Mu Y, Cohen J, et al. NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis 2014; 58: 1394-400.
42. Hall JF, Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg 2008; 196: 384-8.
43. Guillemin I, Marrel A, Lambert J, et al. Patients' experience and perception of hospital-treated Clostridium difficile infections: a qualitative study. Patient 2014; 7: 97-105.
44. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55(suppl 2): S88-92.